본문 바로가기
KERD
논문KCI 등재

Quetiapine Related Acute Paralytic Ileus in a Bipolar I Disorder Patient with Successful Low Dose Amisulpride Substitution: A Case Report

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

The mechanism of medication-induced gastrointestinal hypomotility is primarily caused by muscarinic cholinergic antagonism. This effect may cause constipation and paralytic ileus, which may lead to fatal complications. A 51-year-old woman was admitted due to manic episode recurrence. She developed paralytic ileus under quetiapine use and treated successfully under low dose amisulpride use. The related mechanism, associated risk factors, and the rationale for medication switch are discussed.

Abstract

The mechanism of medication-induced gastrointestinal hypomotility is primarily caused by muscarinic cholinergic antagonism. This effect may cause constipation and paralytic ileus, which may lead to fatal complications. A 51-year-old woman was admitted due to manic episode recurrence. She developed paralytic ileus under quetiapine use and treated successfully under low dose amisulpride use. The related mechanism, associated risk factors, and the rationale for medication switch are discussed.

참고문헌 (14)

  1. Nielsen J, "Risk factors for ileus in patients with schizophrenia", Schizophr Bull, 38, pp.592~598 (2012)[DOI]
  2. Kitahata R, "Relapse of ileus in patients with psychiatric disorders: A 2-year chart review", Gen Hosp Psychiatry, 38, pp.31~36 (2016)[DOI]
  3. De Hert M, "Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study", BMC Gastroenterol, 11, pp.17~ (2011)[DOI]
  4. Chew ML, "A model of anticholinergic activity of atypical antipsychotic medications", Schizophr Res, 88, pp.63~72 (2006)[DOI]
  5. De Hert M, "Second-generation antipsychotics and constipation: a review of the literature", Eur Psychiatry, 26, pp.34~44 (2011)
  6. Ramamourthy P, "Risperidone associated paralytic ileus in schizophrenia", Indian J Psychol Med, 35, pp.87~88 (2013)[DOI]
  7. Perrault G, "Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2", D3 dopamine receptor antagonist activity and limbic selectivity, 1997, pp.280, 73~82
  8. Thomas P, "Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial", Neuropsychiatr Dis Treat, 4, pp.675~686 (2008)
  9. Hong CC, "Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome", Aust N Z J Psychiatry, 49, pp.757~758 (2015)
  10. Carta MG, "An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients", Clin Pract Epidemiol Ment Health, 2, pp.19~ (2006)[DOI]
  11. Rodrigo C, "Hypothyroidism causing paralytic ileus and acute kidney injury - case report", Thyroid Res, 4, pp.7~ (2011)[DOI]
  12. Ramaswamy S, "Quetiapine-induced hypothyroidism", J Psychiatry Neurosci, 30, pp.57~ (2005)
  13. Mendhekar DN, "Amisulpride-induced tardive dyskinesia and possible association of dyskinesia with hypothyroidism", J Neuropsychiatry Clin Neurosci, 21, pp.104~105 (2009)[DOI]
  14. Bou Khalil R, "Thyroid adverse effects of psychotropic drugs: a review", Clin Neuropharmacol, 34, pp.248~255 (2011)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (15건)